Cargando…
PLGA Carriers for Controlled Release of Levofloxacin in Anti-Tuberculosis Therapy
Levofloxacin (LFX) is a highly effective anti-tuberculosis drug with a pronounced bactericidal activity against Mycobacterium tuberculosis (Mtb). In this work, an “organic solvent-free” approach has been used for the development of polylactic-co-glycolic acid (PLGA) microparticles and scaffolds cont...
Autores principales: | Antonov, Evgeny N., Andreevskaya, Sofya N., Bocharova, Irina V., Bogorodsky, Sergei E., Krotova, Larisa I., Larionova, Elena E., Mariyanats, Alexandra O., Mishakov, Gennady V., Smirnova, Tatiana G., Chernousova, Larisa N., Popov, Vladimir K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227258/ https://www.ncbi.nlm.nih.gov/pubmed/35745846 http://dx.doi.org/10.3390/pharmaceutics14061275 |
Ejemplares similares
-
Mycobacterium tuberculosis Type II Toxin-Antitoxin Systems: Genetic Polymorphisms and Functional Properties and the Possibility of Their Use for Genotyping
por: Zaychikova, Marina V., et al.
Publicado: (2015) -
Draft Genome Sequence of a Mycobacterium heckeshornense Clinical Isolate
por: Ustinova, V., et al.
Publicado: (2018) -
First Draft Genome Sequence of a Mycobacterium gordonae Clinical Isolate
por: Ustinova, V., et al.
Publicado: (2016) -
New Flexible Analogues of 8-Aza-7-deazapurine Nucleosides as Potential Antibacterial Agents
por: Khandazhinskaya, Anastasia, et al.
Publicado: (2023) -
Wide-Ranging Multitool Study of Structure and Porosity of PLGA Scaffolds for Tissue Engineering
por: Buzmakov, Alexey V., et al.
Publicado: (2021)